Melasma is one of the most persistent and challenging forms of hyperpigmentation on our face. It typically appears as symmetrical brown or gray‑brown patches on sun‑exposed areas of our face, most commonly the cheeks, forehead, upper lip, and jawline. While it is not harmful to our health, melasma can negatively impact our self‑confidence because it is resistant to conventional treatments, recurs easily, and often requires professional, evidence‑based intervention to effectively manage the condition.
At Lynn Aesthetic, we approach melasma treatments with a deep understanding of its biological complexity and the underlying triggers. This comprehensive guide explains what melasma is, why it occurs, how it’s classified, why it’s difficult to treat, and what evidence‑based management strategies are available, both in‑clinic procedures and long‑term care.
What Is Melasma?
Melasma is a type of acquired hyperpigmentation characterised by irregular patches of darker skin, predominantly on the face. Unlike freckles or sunspots, melasma involves a persistent overproduction and uneven distribution of melanin that continues even after visible pigmentation appears to fade. Clinical research revealed elevated melanocyte activity and abnormal melanosome distribution, which contribute to the depth and persistence of the skin discoloration.
Melasma often affects individuals with medium to darker skin tones (Fitzpatrick skin types III–VI) more frequently, although it can occur in any skin type. It is particularly common in women of childbearing age, but men can also be affected.
Clinically, melasma presents as bilateral, symmetrical patches that can change with seasons, hormonal shifts, or sun exposure. Unlike post‑inflammatory hyperpigmentation, which resolves over time once the trigger is removed, melasma tends to recur unless underlying factors are continuously managed.
What Causes Melasma?
The root causes of melasma is multifactorial. A combination of environmental, hormonal, genetic, and inflammatory triggers stimulates melanin synthesis and drives pigment retention. Understanding these factors is essential for effective management.
Sunlight and Visible Light Exposure
Melasma is primarily triggered by ultraviolet radiation (UV). Melanocytes are stimulated to make more melanin by UV rays that penetrate the skin. Research also shows that high‑energy visible (HEV) light contributes to melanin production and can worsen melasma, even on cloudy days or indoors if exposed to screens or daylight.
This is why broad‑spectrum sunscreens that protect against UVA, UVB, and HEV light are crucial in melasma prevention and treatmentment.
Hormonal Influences
Our hormones play a significant role in the development of melasma. Many individuals first develop melasma during pregnancy, which is why it is sometimes called “the mask of pregnancy.” It also commonly appears or worsens in people taking oral contraceptives or undergoing hormone replacement therapy. Estrogen and progesterone influence melanocyte activity and can heighten melanin production.
Genetic Predisposition
Family history is a known risk factor. Individuals with family members who have melasma are more likely to develop the condition, indicating that genetics influences how melanocytes respond to various triggers.
Inflammation and Dermal Changes
Emerging research shows that melasma is associated not only with epidermal pigmentation but also with dermal changes such as increased vascularity and subtle inflammation. These changes can reinforce pigment retention and make treatment more resistant.
How Is Melasma Classified?
Melasma can be classified in two clinically relevant ways: by depth of pigment and facial distribution pattern.
Depth of Pigment
-
Epidermal Melasma:
Pigment is primarily in the upper layers of the skin. This form usually responds better to topical treatments and professional peels.
-
Dermal Melasma:
Pigment is deeper within the dermis, making it more resistant to treatment.
-
Mixed Melasma:
Features both epidermal and dermal pigment and often requires combination therapies for optimal results.
Facial Distribution Pattern
-
Centrofacial Pattern:
The centrofacial pattern is the most common pattern and involves the forehead, cheeks, upper lip, nose, and chin.
-
Malar Pattern:
The malar pattern is restricted to the malar cheeks on the face
-
Mandibular Pattern:
Mandibular melasma is present on the jawline and chin. It often affects older individuals and may be more related to severe photodamage
Understanding both the depth and the pattern is essential for choosing the most effective treatment protocol for melasma.
Why is it Difficult to Find Effective Melasma Treatment
Melasma is difficult to treat for several reasons:
-
Active Melanocyte Stimulation: Melanin production continues even after the pigmentation becomes visible.
-
Multiple Triggers: Sunlight, hormones, genetics, and inflammation all contribute to the development of melasma.
-
Barrier Sensitivity: Melasma‑prone skin is often sensitive and reactive, which limits how aggressively it can be treated. For example, treatments like hydroquinone can reduce pigmentation but may irritate sensitive skin, making it crucial to balance efficacy with barrier protection through gentler options like azelaic acid or sunscreen adherence.
-
Recurrence: Melasma frequently recurs if sun protection and maintenance are inadequate and the adequacy differs by the individual.
Because of these complexities, simple topical melasma treatment agents or over‑the‑counter products often provide limited results. Evidence supports a multi‑pronged approach that combines professional procedures, advanced formulations, and diligent sun protection to achieve sustainable results.
Evidence‑Based Melasma Treatment Strategies
Peer‑reviewed evidence supports several core approaches from daily habits to clinical treatments. Each modality contributes to a broader plan that addresses both visible pigmentation and the biological drivers beneath.
Daily Photoprotection: The Foundation
Sun exposure is the most consistent trigger for melasma, and its effects are cumulative. Daily use of broad‑spectrum sunscreen that protects against UVA, UVB, and visible light is essential. Reapplication every two hours when outdoors is recommended, as is physical protection such as wide‑brimmed hats, UPF clothing, and shade.
Clinical evidence shows that strict photoprotection slows melanocyte stimulation and enhances the long‑term success of other treatments.
Topical Prescription Agents
Certain active ingredients have shown breakthrough results in clinical testing for the effective melasma treatment.
1. Hydroquinone
Hydroquinone is considered a gold‑standard tyrosinase inhibitor. It interferes with melanin synthesis and has shown significant efficacy when used in professional contexts. However, incorrect or prolonged unsupervised use can lead to irritation or paradoxical pigmentation, making clinician guidance essential.
2. Triple Combination Therapies
Combination products that include hydroquinone, retinoids, and corticosteroids have demonstrated superior results compared with monotherapies. By targeting multiple pigmentation pathways simultaneously, they reduce melanin production, promote renewal, and reduce inflammation.
3. Alternative Brighteners
Agents such as azelaic acid, niacinamide, tranexamic acid, and cysteamine show promise in clinical research for reducing pigmentation with lower irritation risk, especially in sensitive skin.
Professional Chemical Peels
Chemical peels remove superficial layers of pigment‑laden cells and accelerate skin renewal. When chosen and administered by trained clinicians, peels can significantly improve melasma. A 2024 systematic review of melasma treatments showed that chemical peels provide visible improvement, especially when combined with other modalities.
At Lynn Aesthetic, our Melasma Peel Facial treatment uses medical‑grade formulations that target the root cause of your melasma and skin type to ensure minimal disruption to skin microbiome with minimal downtime.
Laser and Light-Based Therapies
Lasers targeting pigment can be effective but require careful calibration. Certain wavelengths (such as picosecond and nanosecond pulse lasers) break pigment into tiny particles that the body can clear more efficiently. Clinical trials demonstrate moderate benefit in selected cases, especially where deeper pigment is involved, but care must be taken in darker skin types to avoid post‑inflammatory hyperpigmentation.
Targeted laser options can be discussed during your personalised consultation.
Adjunctive Supportive Treatments
Emerging evidence supports the use of regenerative boosters, microneedling, and barrier‑supportive therapies as adjuncts to melasma treatment. These approaches can enhance collagen production, strengthen barrier integrity, and improve overall skin resilience, which helps reduce pigment persistence and improve long‑term outcomes.
Maintenance and Long‑Term Care
Melasma treatment is not a one‑time fix. Because of its chronic and recurrent nature, ongoing care is necessary:
-
Strict daily photoprotection
-
Consistent use of prescribed topical agents
-
Periodic professional treatments to address stubborn pigmentation
-
Gentle, barrier‑supportive skincare to reduce inflammation
Barrier integrity plays a critical role in preventing rebound pigmentation. When the skin barrier is weak, inflammation increases, which can reactivate melanocyte pathways.
Realistic Expectations for Outcomes
Melasma treatment is a journey rather than a one-time event. Most clinical protocols involve a series of sessions before significant improvements become noticeable. Even after achieving results, ongoing maintenance treatments and consistent sun protection are crucial to prevent recurrence. Research consistently indicates that using a combination of treatment methods leads to the most lasting improvements.
When to Seek Professional Evaluation
If your pigmentation continues despite diligent sun protection and proper at-home care, or if products cause irritation, it's time to consult a professional. A professional assessment by a doctor who is experienced in the effective treatment of melasma can determine :
-
Depth of pigment (epidermal, dermal, or mixed)
-
Triggers contributing to your melasma
-
Appropriate, evidence‑based combinations of treatment
At Lynn Aesthetic, we begin with an in‑depth skin consultation that informs a personalised treatment plan tailored to your skin type, pigmentation pattern, and lifestyle.
Why Choose Lynn Aesthetic
Lynn Aesthetic was founded by internationally certified specialists with decades of experience in Asian skin health and aesthetic medicine. Our approach to melasma focuses on:
-
Evidence‑based treatment pathways
-
Barrier‑smart protocols that minimise irritation
-
Customised programs designed for long‑term results
-
Safe, progressive improvement without unnecessary downtime
Our clinical expertise, combined with understanding the unique characteristics of Asian skin, Effective treatment options for melasma are available with a focus on both efficacy and tolerability. Melasma is a complex pigmentation condition influenced by UV exposure, hormonal factors, genetic predisposition, and dermal inflammation. Due to its chronic and recurring nature, successful management requires a combination of consistent sun protection, evidence-based topical treatments, professional peels, advanced light or laser therapies, and ongoing maintenance.
At Lynn Aesthetic, we take a clinically informed approach that enables you to improve pigmentation safely and sustainably while ensuring long-term skin health.Ready to take control of your pigmentation?
Discover personalised melasma care starting with a professional consultation. Book your appointment at Lynn Aesthetic today:
Citations
-
Pigmentation Mechanisms and Melasma Review — PubMed PMID: 31802394
-
Histopathology of Melasma — PMC12207721
-
Genetic Predisposition Studies — PubMed PMID: 28726212
-
Chemical Peel Efficacy in Melasma — PubMed PMID: 38530985
-
Laser and Light in Pigmentary Disorders — PubMed PMID: 23881551
-
Triple‑Combination Therapies in Dermatology — Academic OUP, British Journal of Dermatology